semaglutide stomach paralysis legal team in louisiana Ozempic, Mounjaro manufacturers sued over risk of Ozempic/Wegovy/Rybelsus Claims Ozempic, Mounjaro manufacturers sued by

Metabolites (2023) 13:581

The range of gallbladder complications linked to Ozempic spans from mild to life-threatening: Acute cholecystitis requiring emergency hospitalization and surgical intervention Cholelithiasis (gallstones) causing severe right upper quadrant pain, especially after fatty meals Biliary colic with episodes of intense pain lasting hours Choledocholithiasis where stones migrate to the common bile duct causing obstruction Ascending cholangitis, a life-threatening infection of the bile ducts Pancreatitis secondary to gallstone migration Post-cholecystectomy syndrome with ongoing digestive problems after gallbladder removal Increased surgical risks due to delayed gastric emptying affecting anesthesia safety FDA investigations revealed particularly concerning patterns, with 47% of acute cholecystitis cases developing within 90 days of starting Ozempic, suggesting an immediate and dramatic effect on gallbladder function

Assessing the risk for gout with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a population-based cohort study

Around 59% of eligible patients receive GLP-1 therapies through reimbursement frameworks, improving treatment adoption

Gill told Action News that demand for the Wegovy pill is already growing after its release was announced Monday